United States· US:51407-918_57d77a92-1e20-5a1c-e063-6394a90ae710
Bexagliflozin
A bexagliflozin product containing bexagliflozin, registered in United States by Golden State Medical Supply, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- BEXAGLIFLOZIN
- Manufacturer
- Golden State Medical Supply, Inc.
- Country
- United States (US)
- ATC code
- A10BK08
- ATC class
- Bexagliflozin
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1151407-918-30
- ndc1151407-918-90
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bexagliflozin in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c45716b9-1867-4300-a423-1893d16151e9 GET /v1/drugs/c45716b9-1867-4300-a423-1893d16151e9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "20",
"substance": "BEXAGLIFLOZIN",
"productndc": "51407-918",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA214373",
"marketing_category": "NDA AUTHORIZED GENERIC"
}See everything about bexagliflozin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.